TP53 and osteosarcoma: Piperidinones AM-8553 (Rew et al., 2012) and AMG232 are another type of selective piperidinone inhibitor of MDM2–p53 interaction, which also showed anti-tumor effect in SJSA-1 osteosarcoma xenograft mouse model.